Title: What is the role of admission <scp>HbA1c</scp> in managing <scp>COVID</scp>‐19 patients?
Abstract: Journal of DiabetesVolume 13, Issue 3 p. 273-275 LETTER TO THE EDITOR What is the role of admission HbA1c in managing COVID-19 patients? 入院糖化血红蛋白在新冠肺炎患者管理中的作用是什么? Thirunavukkarasu Sathish, Corresponding Author Thirunavukkarasu Sathish [email protected] orcid.org/0000-0002-2016-4964 Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada Correspondence Thirunavukkarasu Sathish, Population Health Research Institute (PHRI), McMaster University, Hamilton, ON L8L 2X2, Canada. Email: [email protected]Search for more papers by this authorYingting Cao, Yingting Cao orcid.org/0000-0001-8555-0463 Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, AustraliaSearch for more papers by this author Thirunavukkarasu Sathish, Corresponding Author Thirunavukkarasu Sathish [email protected] orcid.org/0000-0002-2016-4964 Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada Correspondence Thirunavukkarasu Sathish, Population Health Research Institute (PHRI), McMaster University, Hamilton, ON L8L 2X2, Canada. Email: [email protected]Search for more papers by this authorYingting Cao, Yingting Cao orcid.org/0000-0001-8555-0463 Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, AustraliaSearch for more papers by this author First published: 03 December 2020 https://doi.org/10.1111/1753-0407.13140Citations: 15Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Ling P, Luo S, Zheng X, Cai G, Weng J. Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: a multicenter observational study. J Diabetes. 2020; 13: 89-93. https://doi.org/10.1111/1753-0407.13121. 10.1111/1753-0407.13121 PubMedWeb of Science®Google Scholar 2Lippi G, Sanchis-Gomar F, Henry BM. Response to: is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13127. Web of Science®Google Scholar 3Bloomgarden Z. Does glycemic control affect outcome of COVID-19? J Diabetes. 2020; 12(12): 868-869. 10.1111/1753-0407.13116 Web of Science®Google Scholar 4Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8(9): 782-792. 10.1016/S2213-8587(20)30238-2 CASPubMedWeb of Science®Google Scholar 5Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2020; 17: 11–30. https://doi.org/10.1038/s41574-41020-00435-41574. 10.1038/s41574-020-00435-4 PubMedWeb of Science®Google Scholar 6Liu Z, Bai X, Han X, et al. The association of diabetes and the prognosis of COVID-19 patients: a retrospective study. Diabetes Res Clin Pract. 2020; 169:108386. 10.1016/j.diabres.2020.108386 CASPubMedWeb of Science®Google Scholar 7Liu L, Wei W, Yang K, et al. Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019. J Diabetes Investig. 2020. https://doi.org/10.1111/jdi.13431. 10.1111/jdi.13431 Web of Science®Google Scholar 8Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020; 63(8): 1500-1515. 10.1007/s00125-020-05180-x CASPubMedWeb of Science®Google Scholar 9Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020; 164: 108214. https://doi.org/10.1016/j.diabres.2020.108214. 10.1016/j.diabres.2020.108214 CASPubMedWeb of Science®Google Scholar 10Lee TF, Drake SM, Roberts GW, et al. Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness. Crit Care Med. 2020; 48(2): e115-e122. 10.1097/CCM.0000000000004133 CASPubMedWeb of Science®Google Scholar 11Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001; 32(10): 2426-2432. 10.1161/hs1001.096194 CASPubMedWeb of Science®Google Scholar 12Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206): 773-778. 10.1016/S0140-6736(99)08415-9 CASPubMedWeb of Science®Google Scholar 13Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015; 100(12): 4490-4497. 10.1210/jc.2015-2660 CASPubMedWeb of Science®Google Scholar 14Luethi N, Cioccari L, Tanaka A, et al. Glycated hemoglobin A1c levels are not affected by critical illness. Crit Care Med. 2016; 44(9): 1692-1694. 10.1097/CCM.0000000000001656 CASPubMedWeb of Science®Google Scholar 15Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2020: In Press. https://doi.org/10.1111/dom.14269. 10.1111/dom.14269 PubMedWeb of Science®Google Scholar 16Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2020. https://doi.org/10.1016/j.diabet.2020.1010.1002. 10.1016/j.diabet.2020.10.002 PubMedWeb of Science®Google Scholar 17Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020; 22: 1897–1906. https://doi.org/10.1111/dom.14099. 10.1111/dom.14099 CASPubMedWeb of Science®Google Scholar 18Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020; 167: 108382. https://doi.org/10.1016/j.diabres.2020.108382. 10.1016/j.diabres.2020.108382 CASPubMedWeb of Science®Google Scholar 19Sathish T, de Mello GT, Cao Y. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13125. PubMedWeb of Science®Google Scholar 20Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. http://doi.org/10.1016/j.dsx.2020.12.024. PubMedGoogle Scholar Citing Literature Volume13, Issue3March 2021Pages 273-275 This article also appears in:COVID-19 and Diabetes Management ReferencesRelatedInformation